Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please fine enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company Scheduled to be ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gennex Laboratories Limited has announced a board meeting scheduled for May 30, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with statutory auditors' reports. The notice was published in Business Standard (English) and Saksham (Telugu local) newspapers on May 20, 2026, in compliance with SEBI LODR Regulation 47. The company is listed on BSE (Code: 531739), Ahmedabad Stock Exchange, and Calcutta Stock Exchange.
This is a routine regulatory filing announcing an upcoming board meeting. The actual impact on the stock will depend on the financial results to be approved on May 30, 2026. Investors should watch for the financial results announcement after the meeting.